 |
 |
 |
|
|
||
|
|
Nafcillin |
|
Comparative Western Blot BSMC and NHLF were compared by Western Blot for NKCC cotransporter protein content. Equal numbers of cells were lysed, the proteins were separated by SDS-PAGE, and transferred onto a polyvinylidene difluoride membrane. The membrane was probed with the T4 monoclonal antibody 1: 1000 ; to the NKCC cotransporter Developmental Studies Hybridoma Bank, Iowa City, IA ; and the bands were visualized using a chemiluminescence kit ECL, Amersham Pharmacia Biotech, Piscataway, NJ ; . To normalize for protein loading, the membrane was also probed with a monoclonal antibody to beta-actin Sigma, St. Louis, MO ; and then finally stained for total protein with amido-black BioRad, Hercules, CA.
II. Diagnostic testing A. ECG changes. During the initial few days, diffuse limb leads and precordial leads ; ST segment elevations are common in the absence of reciprocal ST segment depression. PR segment depression is also common and reflects atrial involvement. B. The chest radiograph is often unrevealing, although a small left pleural effusion may be seen. An elevated erythrocyte sedimentation rate and C-reactive protein CRP ; and mild elevations of the white blood cell count are also common. C. Labs: CBC, SMA 12, albumin, viral serologies: Coxsackie A & B, measles, mumps, influenza, ASO titer, hepatitis surface antigen, ANA, rheumatoid factor, anti-myocardial antibody, PPD with candida, mumps. Cardiac enzymes q8h x 4, ESR, blood C&S X 2. D. Pericardiocentesis: Gram stain, C&S, cell count & differential, cytology, glucose, protein, LDH, amylase, triglyceride, AFB, specific gravity, pH. E. Echocardiography is the most sensitive test for detecting pericardial effusion, which may occur with pericarditis. III. Treatment of acute pericarditis nonpurulent ; A. If effusion present on echocardiography, pericardiocentesis should be performed and the catheter should be left in place for drainage. B. Treatment of pain starts with nonsteroidal antiinflammatory drugs, meperidine, or morphine. In some instances, corticosteroids may be required to suppress inflammation and pain. C. Anti-inflammatory treatment with NSAIDs is firstline therapy. 1. Indomethacin Indocin ; 25 mg tid or 75 mg SR qd, OR 2. Ketorolac Toradol ; 15-30 mg IV q6h, OR 3. Ibuprofen Motrin ; 600 mg q8h. D. Morphine sulfate 5-15 mg intramuscularly every 4-6 hours. Meperidine Demerol ; may also be used, 50100 mg IM IV q4-6h prn pain and promethazine Phenergan ; 25-75 mg IV q4h. E. Prednisone, 60 mg daily, to be reduced every few days to 40, 20, 10, and 5 mg daily. F. Purulent pericarditis 1. Nafcillin or oxacillin 2 gm IV q4h AND EITHER 2. Gentamicin or tobramycin 100-120 mg IV 1.5-2 mg kg then 80 mg 1.0-1.5 mg kg ; IV q8h adjust in renal failure ; OR 3. Ceftizoxime Cefizox ; 1-2 gm IV q8h. 4. Vancomycin, 1 gm IV q12h, may be used in place of nafcillin or oxacillin. The prevalence of multiply resistant Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK diphtheroids causing serious infections in immunocompromised patients has increased at this institution during the past several years. The P. aeruginosa strains are often resistant to extended-spectrum penicillins such as ticarcillin and mezlocillin. Moreover, many strains have acquired resistance to the aminoglycoside antibiotics gentamicin [33%], tobramycin [4%], and amikacin [10%] ; . In a few clinical situations, P. aeruginosa isolates have been resistant to all currently available antimicrobial agents, including piperacillin, ceftazidime, and imipenem, resulting in patient mortality. In addition, coagulase-negative staphylococci and JK diphtheroids have become frequent isolates from blood cultures in the same immunosuppressed population. Susceptibility of coagulase-negative staphylococci to methicillin and nafcillin has waned to 17% at this institution. Most of these strains are multiply resistant, as has been reported at other centers 1, 9 ; . Group JK corynebacteria are very resistant, lipophilic diphtheroids thought to colonize the skin and gastrointestinal tract of immunocompromised patients. These organisms invade the blood stream, producing clinical sepsis, and have caused serious infections of intravascular catheters. Vancomycin is the drug of choice for infections caused by both methicillin-resistant S. epidermidis and JK diphtheroids. However, we have observed several patients who have developed severe toxicity with the use of this antibiotic, including the "Redman's syndrome, " true drug-allergic skin rashes, liver abnormalities, and neutropenia 7, 15 ; . Because of infections in immunocompromised patients caused by multiply resistant Pseudomonas strains and problems associated with vancomycin administration in some patients, alternative antimicrobial agents are needed. In this study, we evaluated the in vitro susceptibilities, assessed by MICs and MBCs comparing ciprofloxacin with norfloxacin and several broad-spectrum beta-lactam antibiotics and aminoglycosides in 71 multiply resistant strains of P. aeruginosa. In addition, the MICs and MBCs for clini. ORDINANCE #1432 AN ORDINANCE ESTABLISHING MANDATORY RECYCLING IN THE BOROUGH OF NORTH ARUNGTON; ESTABLISHMENTS THE RULES AND REGULATIONS FOR THE SEPARATION OF USED NEWSPAPERS. GLASS FOOD -AND~BEVERAGE CONTAINERS. ALUMINUM BEVERAGE CONTAINERS AND CORRUGATED CARDBOARD, FOR THE PURPOSE OF RECYCLING."FROM THE SOLID WASTE STREAM; PROMULGATING RULES AND REGULATIONS FOR THE COLLECTION OF THESE MATERIALS AND PRESCRIBING PENALITIES FOR THE VIOLATION THEREOF. THIS O R D SUPERSEDE ORDINANCE#1213. WHEREAS, pursuant to Public Law 1987. Chapter 102. the 1987 Statewide Mandatory Sources Separation a n d Recycling Act a n d the Solid Waste Management Act, each municipality is required to make provisions forthe recycling of at least three 3 ; recyclable materials: a n d WHEREAS, the separation and removal of these certain desjjjnqted a c c materials, for the purpose of recycling, will serve the public interest by reducing solid waste and conserving our material resources: and .WHEREAS. It. Is. In the best. interest of the citizens of the North Arlington Borough to recycle the items of used newspapers, glass food and beverage containers, corrugated cardboard and aluminum cans; and WHEREAS, it is necessary to establish the rules and regulations for the separation, collection and disposal of said materials; NOW. THEREFORE. 8E IT ORDAINED by the Mayor and Council of the North Arlington Boro. County of Bergen, and State of New Jersey, as follows: SECTION I - DEFINITIONS: 1. CORRUGATED CARDBOARD - the term corrugated cardboard as used herein shall be deemed to include cardboard containers used primarily for the packaging, boxing and or transporting of products of any type. 2. GLASS FOOD AND BEVERAGE CONTAINERS - the term glass food a n d beverage containers as used herein shall be deemed to include all bottles and jars made entirely of glass, devoid of metal caps and rings and used In the storage of food and beverages. Specifically excluded are blue glass a n d flat glass, commonly known as window glass, light bulbs, and fixtures. 3. ALUMINUM BEVERAGE CANS - the term aluminum beverage cans as used herein shall be deemed to Include only those containers made entirely of aluminum and used solely for the packaging of beverages. 4. HAZARDOUS WASTE - the term hazardous waste as used herein shall be deemed to Include all waste as defined In "N.J.S.A. 13: lfc-3b. N.J.S.A. 13; 1E-51; and N.JAC. 7: 26-8.1 et seq. 5. DWELLING UNIT - the term dwelling unit as used herein shall be deemed to Include any one-family, two-famlty or multi-family homes; apartmentsand high rises, condominiums a n d cooperatives. 6. DESIGNATED RECYGLABLE MATERIALS - shall mean me following recycling materials which are to be source separated In the Borough pursuant to PL. 1987.Ch. 102 ction3 N.J.S.A. 13: 1E-99.13 ; : leaves. aluminum cans, newspapers and white goods. 7. DISPOSITION or DISPOSITION OF DESIGNATED RECYCLABLE MATERIALS - shall mean the transportation, placement, reuse, sale, donation, transfer or temporary storage for a period not exceeding six 6 ; months of designated recyclable materials for all possible uses except for disposal as solid waste. 8. MUNICIPAL SOUD WASTE STREAM - shall mean all residential, commercial and Institunonai solid waste generated" * within the boundaries of the Borough, as measured In tons. 9. NEWSPAPERS - shall mean paper of the type commonly referred t o as "newsprint" and distributed as stated Intervals, usually dairy or weekly, having printed thereon news a n d opinions a n d advertisements and other matters of public Interest. 10. PERSONS - shall mean any person, firm, partnership, association, corporation, company or organization of any kind. 11. PROPERTY - shall mean all residential, commercial and Institutional property In the North Arlington Borough. 12. RECYCLABLE MATERIALS shall mean those aluminum cans, newspapers and white goods which would otherwise become municipal solid waste and which are to be collected, separated or processed and returned to the economic mainstream In the form of raw materials or products, 13. RECYCLING CENTER shall m e a designed and operated solely for receiving, storing, processing a n d transferring source separated leaves, aluminum cans, newspapers and white goods. 14. RECYCLING SERVICES shall mean the services provided by persons engaged In the business of recycling, including the cSllectton, processing, storage, purchase, sate or disposition or any combination thereof, of recyclable materials. 15. SOURCE SEPARATED RECYCLABLE MATERIALS - shall mean recyclable materials, including only leaves, aluminum cans, newspapers and white goods, which are kept separate and apart from all other residential, commercial and Institutional solid waste by the generator thereof for the purposes of collection, disposition a n d recycling. 16. WHITE GOODS - shall mean 1he following types of appliances: freezers, refrigerators, dishwashers, washing machines, dryers, hot water heaters, stoves and the Wee. 17. PUBLIC OR PRIVATE INSTITUTIONS-the term public or private Institutions as used herein shall b e deemed to include all Municipal and State government facilities; all religious, educational and healthcare facilities; any a n d all pubic and or private cMc organizations a n d all nonprofit or for profit organizations. 18. COMMERCIAL AND INDUSTRIAL ESTABLISHMENTS the term commercial a n d Industrial establishments as used herein shall be deemed to Include an public or private establishment!. Including. but not limited to. those manufacturing, retailing a n d service establishments; food establishments In business for the purpose of consumption, on or off premises, as w e l food distri. Immunohistochemistry Duplicate immunostaining experiments for the detection of ER, PgR, p5B. bcl-2, c-erbB-2 and Ki67 were performed on consecutive serial paraffin sections of the core biopsy before treatment and of the residual tumor obtained at surgery. The stained slides were blindly evaluated. Only nuclear immunoreactivity was evaluated for ER. PgR, p53, Ki67, while cytoplasmic and membrane immunoreactivity were considered for bcl-2 and c-erbB-2, respectively. For ER, PgR, Ki67 the percentage of immunoreactive cells over at least 2000 neoplastic cells was recorded. For the remaining immunoreactions p53, bcl-2 and cerbB2 ; , the tumors were classified in five groups, according to the percentage of immunoreactive neoplastic and naloxone.
As mentioned above, the methodology is standardized, published and readily available. Nonetheless, we want to give a short description and definition of the set of parameters we consider essential and minimal for a monitoring programme of mountain waters. The rough cost estimates given in Table 12.2 refer to European standards. Twenty-seven isolates of Staphylococcus epidermidis from patients with prosthetic valve endocarditis or infected cerebrospinal fluid shunts were examined for susceptibility to antimicrobial agents. Subpopulations resistant to 20 and 100 ttg of methicillin per ml were present in 63% of the isolates methicillin-resistant isolates ; . Subpopulations resistant to 20 jig of nafcillin and cephalothin per ml were found in every methicillin-resistant isolate but with frequencies 10-50 0.5 and 10-64 * 0.9, respectively ; which were not always detectable by susceptibility testing. Resistance to '1.6 jig of penicillin per ml was found in 80% of isolates. Cephalothin, cefazolin, and cefamandole were more active than cefoxitin or cephradine, and gentamicin was more active than tobramycin or amikacin; rifampin was the single most active agent against all isolates. There was no difference in susceptibility between prosthetic valve endocarditis and cerebrospinal fluid shunt infection isolates. Among methicillin-resistant isolates, the phenotypic expression of resistance to methicillin or nafcillin but not to cephalothin could be enhanced by 48 h incubation with each drug. Isolates containing no methicillin-resistant subpopulations were killed by incubation with methicillin, nafcillin, or cephalothin. High-level resistance to rifampin emerged in both methicillin-resistant and methicillin-sensitive isolates after 8 to 24 incubation with this drug. The presence or absence of antibiotic-resistant subpopulations among S. epidermidis isolates and their selection during treatment should be considered when therapy is devised and namenda. Microvascular insufficiency has also been proposed as a potential component in the pathogenesis of diabetic neuropathy. Results of animal studies have suggested that impaired ganglion blood flow in diabetes could be responsible for neurodegenerative changes in autonomic postganglionic cell bodies 37 ; . In human diabetic neuropathy, impaired nerve! Cillin-gentamicin and oxacillin-tobramycin combinations. Thus, nafcillin-gentamicin and nafcillin-tobramycin were the most effective combinations in reducing viable CFU. Nafcillin was more effective than oxacillin and methicillin in killing enterococci when it was used alone. In combination with gentamicin or tobramycin, nafcillin was also superior to oxacillin and methicillin. Gentamicin was probably more effective than tobramycin when used in combination with methicillin, oxacillin, or methicillin against enterococci. DISCUSSION There have been few data regarding the in vitro susceptibility of enterococci to the penicilTABLE 3. Effect of antibiotic combinations against 30 strains of enterococci and naratriptan. FIG. 1. Synergism of ampicillin and nafcillin against the strain of H. influenzae blood of a patient with osteomyelitis. Gaining Coverage Under Another Employer's Plan In the event that an eligible Associate or an eligible Associate's Dependent elects coverage under a comprehensive medical plan of another employer, the eligible Associate may drop coverage under the Plan for the eligible Associate and or Dependents that have become covered under the other employer's plan. The Associate's election to drop coverage must be on account of and correspond with the change in coverage under the other employer's plan. The election of coverage under the other employer's plan must be permitted under the other employer's plan in accordance with the Internal Revenue Code Section 125 rules ; , or must be made for a period of coverage other than a Calendar Year period of coverage. For example, if an eligible Associate's spouse elects coverage under the spouse's employer's comprehensive medical plan during that plan's June open enrollment period for coverage beginning July 1st ; , and the coverage elected by the spouse covers the eligible Associate, the spouse and all Dependents, the eligible Associate may drop coverage under the Plan. Similarly, if a spouse's employer's plan allows the spouse to elect new coverage because of the introduction of a significant new coverage option, and the spouse elects such coverage for the eligible Associate, the spouse, and all Dependents, then the eligible Associate could drop coverage under the Plan. This rule only pertains to the ability to drop coverage and does not provide for a new right to enroll in coverage or to change coverage level Enhanced, Choice or Basic ; . An eligible Associate may change available coverage categories associate only, associate plus spouse, associate plus child ren ; or family ; , but only if all of the previously covered Dependents are now covered under the other employer's plan. For this purpose, the term "other employer" does not include Wheaton Franciscan affiliated entities who participate in the Plan. Any such election coverage change will be further subject to the election change restrictions described in the Wheaton Franciscan Flexible Benefits Plan. Any such coverage change must be elected within 31 days of the date coverage under the other employer's plan began, and the coverage termination shall become effective as of the Effective Date of Coverage under the other employer's plan. Grandchild An eligible grandchild of a covered Associate may become covered under the Plan on their date of birth provided written application to elect coverage under the Plan is made within 90 days of the date of birth. If coverage under the Plan is elected after the time period specified above, the Associate may, in certain instances, be eligible to enroll the grandchild for coverage under the Plan as specified in the Special Enrollment Provisions and Miscellaneous Enrollment Provisions of the Plan. Please see page 12, "Eligibility for Coverage" for a discussion of who is an eligible grandchild. Legal Guardianship An eligible Dependent child may become covered under the Plan on the date on which such child is placed in the Associate's home pursuant to a court order appointing the Associate as legal guardian for the child. The Associate must make written application to elect coverage under the Plan within 90 days of the date on which the child is placed in the Associate's home pursuant to a court order appointing the Associate as legal guardian for the child. If coverage under the Plan is elected after the time period specified above, the Associate may, in certain instances, be eligible to enroll such child for coverage under the Plan as specified in the Special Enrollment Provisions and Miscellaneous Enrollment Provisions of the Plan. Qualified Medical Child Support Order An eligible Dependent child may become covered under the Plan on the date on which coverage is required to become effective pursuant to a Qualified Medical Child Support Order. Paternity Children born outside of marriage may become eligible Dependents of a covered Associate who is the father. The Associate must make written application to elect coverage under the Plan within 90 days of and narcan! Markets, " said Dan Stokes, executive vice president for J. Stokes & Associates. "The ability to focus at the community level is critical for success." The J. Stokes team timed its pitches to the media for maximum advantage. "We always took the availability of the media, the physician, and the patient into consideration to help Chiron get the best coverage possible, " said Stokes. "With good planning we were able to obtain coverage in multiple dayparts on most network affiliates." Dr. Gerald Miletello is Chief of Oncology at Our Lady of the Lake Regional Cancer Center, one of only 50 medical centers in the country that currently provide the treatment. "We got great feedback over the course of the campaign in the form of calls from all over Louisiana, " he said. "It's the patients who are making the referrals, which is the really exciting part." Dr. Miletello said the center's calls increased by 20 percent during the 90-day campaign, and the majority of the callers said it was the first time they had heard of the treatment. Approximately. Associated with the HEU agreement. As odd as it sounds, natural UF6 destined to be returned to Russia could have remained stranded at USEC indefinitely.Thanks to the March agreement, however, Tenex can take delivery of feed material via account transfer at ConverDyn's Metropolis facility, thereby overcoming the problem that natural UF6 can be shipped to USEC but not delivered back except in the form of LEU. Primary production of conversion services is carried out at four principal locations outside of the Russian Federation and China. Western World nameplate conversion capacity totals 45, 200 MTU as UF6 per year, but when maintenance requirements are taken into account, production capacity falls to about 40, 680 MTU as UF6.The accompanying table gives a hawk's eye view of total world conversion capacity See previous page ; . The planned closure of the BNFL Line 4 HEX Plant, scheduled for March 2006, will decrease the nameplate capacity to 39, 200 MTU as UF6 and the operating capacity to approximately 35, 300 MTU as UF6 and nardil. INTRACELLULAR ACEDOSIS DECREASES Na + BACKGROUND CURRENT AND Na + -Ca2 + EXCHANGE DURING CARDIOPLEGIA. So Ra PARK. Ek Ho LEE Cheol Joo LEE * . Chang Kook SUH. Department of Physiology, and Department of Thoracic and Cardiovascular Surgery * , Inha University College of Medicine, Inchon, Korea. Cellular edema and cardiac arrhythmia are problems of clinical cardioplegia and ischemia of the heart, and those are closely related to intracellular ionic alterations, such as intracellular pH and Na + activity. In our previous study, intracellular pH during ischemic cardioplegia in guinea pig papillary muscle was decreased, in a Nat-dependent way, and the degree of acidosis was larger in 0 Ca2 + cardioplegic solution than 1.8 mM Ca2 + cardioplegic solution Park et al., 1992 ; . The intracellular acidosis can affect the other transmcmbrane Na + movements such as Na + background current and Na + Ca2 + exchange current. Therefore we studied the effects of intcelular pH on Na background current with whole cell clamp method in guinea pig ventricular myocytes, and the effects of intracellular pH on Nat-Ca2 + exchange currernt with giant excised patch clamp method. The results are as follows. 1 ; The Na + background current at 40 mV membrane potential was larger at 0 Ca2 + cardioplegic solution than at 1.8 nM Ca2 + cardioplegic solution. 2 ; Intracellular acidosis decreased the Nat background current. 3 ; Intracellular acidosis also decreased the Nat-Ca2 + exchange current. These results suggest that Na + background current and Nat-Ca2 + exchange may play a major role in regulating intracellular Nat activity during cardioplegia and nafcillin. Mtrd mutations eliminate the contribution of mtr and penb , but not that of pena , to penicillin and nafcillin resistance a with transformants in hand of strain fa19 containing single and various combinations of resistance determinants derived from fa6140 mtrr alone wv30 ; , pena alone wv32 ; , pena and mtrr wv34 ; , and mtrr , pena , and penb wv36 ; , we asked which strains would be most severely affected in their resistance to penicillin following the introduction of mtrd : : kan and natalizumab. [2] D.B.Leeson, "A simple model of feedback oscillator noises spectrum", Proc. IEEE, vol.54, Feb. 1966, pp. 329-330. [3] H.M.Greenhouse "Design of planar rectangular microelectronic inductors", IEEE Trans. On Parts, Hybrid and Packaging, Vol. 10 N.2, June 1974. [4] C.P. Yue, S.S. Wong "On chip spiral inductors with patterned ground shields for Si-based RF IC's", IEEE Journal of solid-state circuits, Vol.33 N.5, May 1998. [5] A. Kyranas, Y. Papananos "A 5GHz Fully Integrated VCO in a SiGe Bipolar Technology", ISCAS 2000, May 28-31, 2000, Geneva, Switzerland. [6] E. Egazi, H. Sjoland, A.A.Abidi "A Filtering Technique to Lower LC Oscillator Phase Noise", IEEE Journal of solidstate circuits, Vol.36 N.12, December 2001. [7] H. Jacobsson, S. Gevorgian, M. Moktari, C. Hedenas, B. Hansson, T.Lewin, H. Berg. W. Rabe and A. Schuppen "Low-Phase-Noise Low Power IC VCOs for 5-8GHz Wireless Applications", IEEE Trans. On Microwave theory and techniques, Vol.58 N.12, December 2000. Acetaminophen Acetoacetic Acid Acetone N-Acetylprocainamide Acetylsalicylic Acid Aspirin ; Albumin Alphenal Amantadine + ; -Amethopterin Amikacin dl-Aminoglutethimide Aminopyrine Amitriptyline Amoxicillin Ampicillin Apomorphine - ; -Arterenol l-Ascorbic Acid Vitamin C ; Aspartame d-Aspartic Acid dl-Aspartic Acid l-Aspartic Acid Atropine Barbituric Acid Benzoic Acid Benzphetamine Benztropine Methane Sulfonate Bilirubin Bromocriptine Mesylate + ; -Brompheniramine Caffeine Cannabidiol Cannabinol Carbamazepine Cephalexin Chloramphenicol Chloroquine + ; -Chlorpheniramine ; -Chlorpheniramine Chlorpromazine Chlorpropamide Chlorprothixene Cimetidine Clemastine Clomipramine Clonidine - ; -Cotinine Creatinine Cyclizine Cyclobenzaprine Cyclosporin A Cyproheptadine Desipramine Diflunisal Digoxin 4-Dimethylaminoantipyrine Diphenhydramine Diphenoxylate 5, 5-Diphenylhydantoin Disopyramide Doxepin Doxylamine + ; --Ephedrine - ; --Ephedrine + ; -Ephedrine ; Ephedrine - ; -Ephedrine ; -Epinephrine - ; -Epinephrine Erythromycin Estriol Estrone-3Sulfate Ethanol Ethosuximide Ethyl-p-Aminobenzoate Ethylenediaminetetraacetic Acid EMDP Secondary Methadone Metabolite ; Fenfluramine Fenoprofen Fentanyl[D] Furosemide Gentamicin Gentisic Acid Glucose dl-Glutethimide Griseofulvin Guaiacol Glyceryl Ester Hexobarbital Human Hemoglobin Hydrochlorothiazide dl Hydroxybutyric Acid o-Hydroxyhippuric Acid 5Hydroxyindole-3-Acetic Acid 5-Hydroxyindole-2-Carboxylic Acid Hydroxyzine Ibuprofen Imipramine Indole-3-Acetic Acid Indole-3-Butyric Acid Indomethacin + ; -Isoproterenol ; Isoproterenol - ; -Isoproterenol Isoxsuprine Kanamycin Ketamine Ketoprofen Labetalol Lidocaine Lithium Carbonate Lysergic Acid Diethylamide LSD ; [E] Melanin Meperidine Meprobamate Mescaline dl-Metanephrine Methaqualone S ; Acid 2-Methyl-3- 3, 4-Dihydroxyphenyl ; -dl-Alanine 2-Methyl-3- 3, 4-Dihydroxyphenyl ; -l-Alanine Methylphenidate Methyprylon ; -Metoprolol Nafcillin Naphazoline -Naphthaleneacetic Acid -Naphthaleneacetic Acid Naproxen Netilmicin Niacinamide Nialamide Nicotinic Acid Nifedipine Nomifensine Nordoxepin[D] Norethindrone Nortriptyline Noscapine Orphenadrine Oxalic Acid Oxymetazoline Papaverine Penicillin G Pentazocine Phenelzine Pheniramine Phenothiazine Phentermine Phenylacetone l-Phenylalanine Phenylbutazone trans-2Phenylcyclopropylamine l-Phenylephrine ; -Phenylpropanolamine Piroxicam Potassium Chloride Prednisolone Primidone Procainamide Prochlorperazine Promazine Promethazine + ; Propoxyphene 2-Propyl-pentanoic Acid Protriptyline Quinidine Quinine Ranitidine Riboflavin Salicylic Acid - ; -Scopolamine Sodium Chloride Sulindac Terbutaline Tetracycline Tetraethylthiuram Disulfide Antabuse ; Tetrahydrozoline Theophylline Thioridazine cis-Thiothixene Tobramycin Triamterene Trifluoperazine Triflupromazine dl-Trihexyphenidyl Trimethobenzamide Trimethoprim Trimipramine Triprolidine Urea Uric Acid Vancomycin ; Verapamil Zomepirac [D] No interference was observed when the compound was tested to 10 g mL. [E] No interference was observed when the compound was tested to 2.5 g mL and natrecor. |
|
|
Copyright © 2007 by Online.blackapplehost.com Inc.